Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Previously owned a position in FIGS, which was closed the day the LBO interest by Story3 Capital was ...

Private equity buyers are seeing value in the scrubs retailer.Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.*Stock prices used were end-of-day prices of Dec. 11, 2024. The video was published on Dec. 12, 2024. ...

Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of companies, the competitive dynamics of the industries where they participate, and buying companies that we would like to hold independently of how the price moves in the future. Most QC calls will be holds, and that is by design. Only a very sm ...

FIGS, Inc. (NYSE:FIGS) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Dana Telsey - Telsey Group Josh Reiss - Raymond James Bob Drbul - Guggenheim Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Nathan Feather - Morgan Stanley Joh ...

| --- | --- | --- | |--------------------------------|-------|-------------------------| | | | | | T | | M | | L | 7 | is MEDICAL LEAR w / ปรี่สี | | GFIGS EarningsPresentation | | | DISCLAIMER Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by FIGS, Inc. (the "Company") or any officer, director, employee, agent or advisor of the Company. This presentation does not purport to be all inclusive or to contain all of the information you may desir ...

For the quarter ended September 2024, Figs (FIGS) reported revenue of $140.21 million, down 1.5% over the same period last year. EPS came in at -$0.01, compared to $0.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $144.11 million, representing a surprise of -2.71%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-40448 FIGS, Inc. (Exact Name of Registrant as Specified in its Charter) Dela ...

FIGS Releases Third Quarter 2024 Financial Results Completed State-of-the-Art Fulfillment Center Transition Announces Minority Investment in OOG, Inc., A New Online Platform for Healthcare Professionals Updates Full Year 2024 Outlook SANTA MONICA, Calif., November 7, 2024 — FIGS, Inc. (NYSE: FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2024 financial results and published a financial highligh ...

Thomas Barwick/DigitalVision via Getty Images FIGS (NYSE:FIGS) 2Q24 results were not spectacular, with the company posting moderate growth and improved guidance, but at the expense of lower margins. The company is spending more on product and marketing to drive the top line. My view on the company and the stock has not changed. FIGS has a good product, but its lack of cost management financed by a high gross margin makes it vulnerable to competition from below. The stock discounts a significant improvement ...

n 0 F I C S Earnings Presentation 6 D USA OFIGS US$ PFIGS 199 MOHAMED H., MD SAVANNAH H., ACNP-C DISCLAIMER Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by FIGS, Inc. (the "Company") or any officer, director, employee, agent or advisor of the Company. This presentation does not purport to be all inclusive or to contain all of the information you may desire in connection with your investigation of the Company. Information provided in this p ...